Profile data is unavailable for this security.
About the company
ResMed Inc. is a holding company. The Company, through its subsidiaries, is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. The Company’s segments include Sleep and Respiratory Care and Software as a Service. SDB includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital software health applications, along with its devices, are designed to provide connected care to improve patient outcomes. Its portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, and cloud-based software and informatics solutions. Its comprehensive out-of-hospital software platforms support the professionals and caregivers.
- Revenue in USD (TTM)4.58bn
- Net income in USD958.38m
- Incorporated1994
- Employees10.14k
- LocationResmed Inc9001 Spectrum Center BlvdSAN DIEGO 92123-1438United StatesUSA
- Phone+1 (858) 746-2400
- Fax+1 (302) 636-5454
- Websitehttps://www.resmed.com/
Mergers & acquisitions
| Acquired company | RMD:NYQ since announced | Transaction value |
|---|---|---|
| KC Machine LLC | 38.07% | 2.60m |
| Somnoware Healthcare Systems Inc | -3.48% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hologic Inc | 3.96bn | 466.50m | 17.12bn | 6.99k | 37.74 | 3.53 | 21.80 | 4.32 | 1.94 | 1.94 | 16.30 | 20.76 | 0.4361 | 2.66 | 5.82 | 566,609.40 | 5.14 | 11.40 | 5.74 | 13.38 | 55.12 | 60.29 | 11.78 | 20.95 | 3.29 | -- | 0.3465 | 0.00 | -17.12 | 4.61 | -64.98 | -- | 7.30 | -- |
| Baxter International Inc | 14.89bn | -38.00m | 17.25bn | 60.00k | -- | 2.11 | 13.81 | 1.16 | -0.0762 | 5.21 | 29.33 | 16.04 | 0.5311 | 3.21 | 5.71 | 248,200.00 | -0.107 | 0.1942 | -0.1338 | 0.2333 | 36.31 | 38.20 | -0.2015 | 0.3674 | 1.01 | 3.58 | 0.625 | 1,398.94 | 2.12 | 5.94 | 97.15 | -- | 0.982 | 9.71 |
| Cooper Companies Inc | 3.67bn | 290.80m | 18.22bn | 15.00k | 92.65 | 2.37 | 27.38 | 4.97 | 0.9896 | 0.9896 | 7.36 | 38.73 | 0.3108 | 1.77 | 5.95 | 244,420.00 | 2.47 | 10.06 | 2.68 | 11.34 | 66.09 | 65.54 | 7.93 | 29.00 | 1.08 | 4.92 | 0.2649 | 0.3469 | 8.61 | 7.24 | -23.74 | -3.66 | 15.18 | 31.95 |
| Align Technology, Inc. | 3.92bn | 462.28m | 19.10bn | 21.61k | 41.80 | 5.08 | 31.74 | 4.88 | 6.07 | 6.07 | 51.44 | 49.94 | 0.6497 | 3.96 | 4.27 | 181,237.60 | 7.67 | 16.34 | 11.51 | 24.14 | 70.06 | 71.72 | 11.80 | 23.16 | 1.09 | -- | 0.00 | 0.00 | 3.42 | 14.45 | 23.09 | 2.15 | -4.46 | -- |
| Steris PLC | 5.44bn | 532.54m | 22.07bn | 17.00k | 41.61 | 3.50 | 27.19 | 4.06 | 5.37 | 3.81 | 54.85 | 63.91 | 0.4971 | 4.51 | 5.62 | -- | 4.88 | 4.03 | 5.32 | 4.41 | 43.23 | 43.50 | 9.82 | 8.20 | 2.34 | 8.76 | 0.3307 | 47.34 | 3.65 | 13.06 | 415.22 | 12.67 | 13.69 | 8.83 |
| West Pharmaceutical Services Inc. | 2.93bn | 568.70m | 23.85bn | 10.60k | 43.17 | 8.92 | 34.39 | 8.15 | 7.58 | 7.58 | 39.09 | 36.72 | 0.7995 | 4.20 | 5.65 | 276,283.00 | 15.08 | 15.61 | 17.99 | 18.65 | 37.15 | 38.06 | 18.86 | 18.47 | 1.95 | -- | 0.0714 | 10.69 | 2.18 | 11.43 | 2.28 | 23.76 | 28.16 | 6.20 |
| Zimmer Biomet Holdings Inc | 7.45bn | 963.80m | 23.93bn | 18.00k | 25.18 | 1.90 | 12.44 | 3.21 | 4.62 | 4.62 | 35.72 | 61.24 | 0.3491 | 0.9052 | 5.27 | 414,027.80 | 4.52 | 2.21 | 5.14 | 2.52 | 71.89 | 71.25 | 12.95 | 7.28 | 0.802 | 7.32 | 0.315 | 38.90 | 6.55 | -1.40 | 252.86 | -- | 9.44 | 0.00 |
| Resmed Inc | 4.58bn | 958.38m | 30.43bn | 10.14k | 31.89 | 6.57 | 26.74 | 6.64 | 6.50 | 6.50 | 31.07 | 31.52 | 0.6777 | 2.20 | 5.99 | 452,086.70 | 14.17 | 13.59 | 15.98 | 15.89 | 55.78 | 56.98 | 20.91 | 19.22 | 1.97 | 25.88 | 0.1786 | 36.66 | 18.02 | 12.53 | 15.15 | 14.63 | 13.40 | 4.68 |
| GE HealthCare Technologies Inc | 19.50bn | 1.57bn | 35.95bn | 51.00k | 22.93 | 4.85 | 16.16 | 1.84 | 3.43 | 3.43 | 42.54 | 16.24 | 0.6013 | 5.45 | 4.51 | 382,254.90 | 5.01 | -- | 6.86 | -- | 40.69 | -- | 8.33 | -- | 0.8335 | 5.27 | 0.5491 | -- | 6.60 | -- | -26.82 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Mar 2024 | 17.13m | 11.65% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 9.01m | 6.12% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 6.30m | 4.28% |
| Geode Capital Management LLCas of 31 Mar 2024 | 3.42m | 2.33% |
| Walter Scott & Partners Ltd.as of 31 Mar 2024 | 2.74m | 1.86% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 1.36m | 0.93% |
| Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 2024 | 1.30m | 0.88% |
| Fidelity Management & Research Co. LLCas of 31 Mar 2024 | 1.25m | 0.85% |
| Invesco Advisers, Inc.as of 31 Mar 2024 | 1.02m | 0.70% |
| BlackRock Advisors (UK) Ltd.as of 31 Mar 2024 | 1.00m | 0.68% |
